Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Sep 2023
Historique:
received: 06 07 2023
revised: 28 08 2023
accepted: 02 09 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

The endocannabinoid system (ECS) regulates various physiological processes, including energy homeostasis and kidney function. ECS upregulation in obese animals and humans suggests a potential link to obesity-induced chronic kidney disease (CKD). However, obesity-induced ECS changes in the kidney are mainly studied in rodents, leaving the impact on obese humans unknown. In this study, a total of 21 lean and obese males (38-71 years) underwent a kidney biopsy. Biochemical analysis, histology, and endocannabinoid (eCB) assessment were performed on kidney tissue and blood samples. Correlations between different parameters were evaluated using a comprehensive matrix. The obese group exhibited kidney damage, reflected in morphological changes, and elevated kidney injury and fibrotic markers. While serum eCB levels were similar between the lean and obese groups, kidney eCB analysis revealed higher anandamide in obese patients. Obese individuals also exhibited reduced expression of cannabinoid-1 receptor (CB1R) in the kidney, along with increased activity of eCB synthesizing and degrading enzymes. Correlation analysis highlighted connections between renal eCBs, kidney injury markers, obesity, and related pathologies. In summary, this study investigates obesity's impact on renal eCB "tone" in humans, providing insights into the ECS's role in obesity-induced CKD. Our findings enhance the understanding of the intricate interplay among obesity, the ECS, and kidney function.

Identifiants

pubmed: 37686443
pii: ijms241713636
doi: 10.3390/ijms241713636
pmc: PMC10487429
pii:
doi:

Substances chimiques

Endocannabinoids 0
Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Israel Science Foundation
ID : 158/18

Références

Neuron. 2021 Aug 4;109(15):2398-2403.e4
pubmed: 34352214
Cannabis Cannabinoid Res. 2019 Mar 13;4(1):10-20
pubmed: 31346545
PLoS One. 2013 Sep 25;8(9):e75547
pubmed: 24086563
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11
pubmed: 35529086
Curr Opin Nephrol Hypertens. 2016 Sep;25(5):459-64
pubmed: 27367912
Nefrologia. 2011;31(4):397-403
pubmed: 21623393
Sci Rep. 2020 Sep 29;10(1):15975
pubmed: 32994521
Dig Liver Dis. 2010 May;42(5):320-30
pubmed: 20207596
PLoS One. 2013 Aug 16;8(8):e72521
pubmed: 23977311
Br J Pharmacol. 2010 Jun;160(3):657-68
pubmed: 20590569
Front Behav Neurosci. 2012 Mar 14;6:9
pubmed: 22457644
Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S66-78
pubmed: 18343566
Int Urol Nephrol. 2020 Nov;52(11):2135-2143
pubmed: 32557377
Kidney Int. 2006 Jul;70(1):199-203
pubmed: 16710348
Nutr Metab (Lond). 2011 Jul 13;8(1):51
pubmed: 21749725
J Endocrinol. 2015 May;225(2):113-24
pubmed: 25804605
Endocrinology. 2012 Mar;153(3):1016-24
pubmed: 22210740
Br J Pharmacol. 2020 Jan;177(1):110-127
pubmed: 31454063
PLoS One. 2020 Apr 9;15(4):e0231328
pubmed: 32271842
J Am Soc Nephrol. 2017 Dec;28(12):3518-3532
pubmed: 28860163
Life Sci. 2005 Aug 19;77(14):1685-98
pubmed: 15963531
Nat Rev Nephrol. 2018 Jun;14(6):361-377
pubmed: 29654297
Front Biosci (Schol Ed). 2016 Jun 01;8(2):264-77
pubmed: 27100705
Obes Surg. 2019 Jan;29(1):268-276
pubmed: 30244333
Int J Nephrol Renovasc Dis. 2014 Feb 18;7:75-88
pubmed: 24600241
J Pathol. 2007 Jun;212(2):209-17
pubmed: 17471468
J Gen Intern Med. 2011 Apr;26(4):379-85
pubmed: 20853156
Nutrients. 2022 Mar 31;14(7):
pubmed: 35406070
Crit Rev Clin Lab Sci. 2021 Aug;58(5):354-368
pubmed: 33556265
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3216-28
pubmed: 23108541
Maturitas. 2012 Feb;71(2):94-103
pubmed: 22137331
Gastroenterol Res Pract. 2014;2014:847539
pubmed: 24729784
Inflamm Regen. 2018 Oct 1;38:28
pubmed: 30288203
Scand J Clin Lab Invest Suppl. 2008;241:78-83
pubmed: 18569971
Nutr Metab Cardiovasc Dis. 2007 Dec;17(10):757-62
pubmed: 17606365
Diabetes. 2010 Apr;59(4):1046-54
pubmed: 20068137
Nat Rev Nephrol. 2017 Mar;13(3):181-190
pubmed: 28090083
Pharmacol Biochem Behav. 2005 Jun;81(2):224-38
pubmed: 15935454
Indian J Nephrol. 2017 Mar-Apr;27(2):85-92
pubmed: 28356657
Neuropsychopharmacology. 2018 Jan;43(1):155-172
pubmed: 28653665
Diabetes Obes Metab. 2019 Jan;21(1):146-159
pubmed: 30091204
Metabolism. 2019 Mar;92:51-60
pubmed: 30458177
Nat Rev Gastroenterol Hepatol. 2012 May 08;9(7):372-81
pubmed: 22565095
Eur J Intern Med. 2018 Mar;49:23-29
pubmed: 29336868
FEBS J. 2016 Oct;283(20):3771-3790
pubmed: 27579669
Prim Care. 2008 Jun;35(2):329-44, vii
pubmed: 18486718
Kidney Int. 2014 Nov;86(5):979-90
pubmed: 24827776
Nephrol Dial Transplant. 2010 May;25(5):1621-6
pubmed: 20037172
Int J Mol Sci. 2021 Jan 02;22(1):
pubmed: 33401711
Diabetes Obes Metab. 2018 Mar;20(3):698-708
pubmed: 29106063
Am J Transplant. 2007 Nov;7(11):2553-60
pubmed: 17868063
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):267-76
pubmed: 26280171
Nephrol Dial Transplant. 2006 Jan;21(1):88-92
pubmed: 16221715
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):637-53
pubmed: 25194181
J Cell Physiol. 2013 May;228(5):917-24
pubmed: 23086807
Nephrol Dial Transplant. 2009 Dec;24(12):3732-8
pubmed: 19596742
Lancet. 2012 Jan 14;379(9811):165-80
pubmed: 21840587
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5420-8
pubmed: 25422468
Vet J. 2007 Jan;173(1):21-30
pubmed: 16324856
Kidney Int. 2006 Nov;70(9):1636-41
pubmed: 16955108
Kidney Int. 2015 Jul;88(1):72-84
pubmed: 25760323
Urol Oncol. 2013 Jul;31(5):682-5
pubmed: 21723753
Am J Kidney Dis. 2014 Oct;64(4):638-52
pubmed: 25085644
Endocrinology. 2012 Mar;153(3):1387-96
pubmed: 22234468
Nat Commun. 2022 Apr 4;13(1):1783
pubmed: 35379807
Front Endocrinol (Lausanne). 2021 Jul 07;12:720734
pubmed: 34305821
Adv Ren Replace Ther. 2004 Jan;11(1):41-54
pubmed: 14730537
FEBS J. 2022 Feb;289(4):901-921
pubmed: 33630415
Kidney Int. 2007 Dec;72(11):1345-57
pubmed: 17882151
Int J Mol Sci. 2016 Apr 14;17(4):562
pubmed: 27089331
Diabetes. 2005 Oct;54(10):2838-43
pubmed: 16186383
J Am Soc Nephrol. 2018 Feb;29(2):434-448
pubmed: 29030466
Lancet. 2005 Jan 22-28;365(9456):331-40
pubmed: 15664230
Int J Obes (Lond). 2007 Apr;31(4):692-9
pubmed: 17224929
J Cell Physiol. 2010 Nov;225(3):654-63
pubmed: 20506110

Auteurs

Anna Permyakova (A)

Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Ariel Rothner (A)

Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Sarah Knapp (S)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah Medical School-The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Alina Nemirovski (A)

Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Danny Ben-Zvi (D)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah Medical School-The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Joseph Tam (J)

Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH